Victrex Research and Development Expenses 2019-2025 | VTXPF
Victrex research and development expenses from 2019 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
|
Victrex Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | $25 |
| 2024 | $22 |
| 2023 | $23 |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2016 | |
| 2015 | |
| 2014 | |
|
Victrex Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-09-30 | |
| 2025-03-31 | |
| 2024-09-30 | |
| 2024-03-31 | |
| 2023-09-30 | |
| 2023-03-31 | |
| 2022-09-30 | |
| 2022-03-31 | |
| 2021-09-30 | |
| 2021-03-31 | |
| 2020-09-30 | |
| 2020-03-31 | |
| 2019-09-30 | |
| 2019-03-31 | |
| 2018-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Basic Materials | Chemicals - Plastics | $0.674B | $0.382B |
| Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Covestro AG (COVTY) | Germany | $14.306B | 0.00 |
| Kuraray (KURRY) | Japan | $3.353B | 13.39 |
| Lightwave Logic (LWLG) | United States | $1.578B | 0.00 |
| Tredegar (TG) | United States | $0.307B | 12.11 |